Sobi™ publishes the report for the third quarter 2018
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces the results for the third quarter 2018. Total revenues grew 45 per cent compared with Q3 2017 (34 per cent at constant exchange rates (CER)) and amounted to SEK 2,315 M. EBITA was SEK 933 M, an increase of 74 per cent for the quarter, and gross margin amounted to 75 per cent. Continued strong growth in Q3 · Total revenues of SEK 2,315 M (1,601) in Q3 and SEK 6,568 M (4,636) YTD(1) · 45 per cent sales growth in the quarter compared with Q3 2017 (34 per cent at CER) · EBITA increased 74 per cent to